z-logo
open-access-imgOpen Access
THREE YEARS' EXPERIENCE WITH THE BIOLOGICAL AGENT DENOSUMAB USED TO TREAT WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS: EFFICACY, SAFETY AND TREATMENT ADHERENCE
Author(s) -
Н. В. Торопцова,
О. А. Никитинская,
А. В. Смирнов
Publication year - 2017
Publication title -
naučno-praktičeskaâ revmatologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.137
H-Index - 9
eISSN - 1995-4492
pISSN - 1995-4484
DOI - 10.14412/1995-4484-2017-261-266
Subject(s) - denosumab , osteoporosis , medicine , postmenopausal osteoporosis , postmenopausal women , oncology , bone mineral

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here